List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 118 studies with search of:   "Thrombocytosis"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Open-Label Study of Oral CEP-701 (Lestaurtinib) in Patients With Polycythemia Vera or Essential Thrombocytosis
Conditions: Polycythemia Vera;   Essential Thrombocytosis
Intervention: Drug: lestaurtinib
2 Recruiting Open Label INCB018424 in Patients With Myelofibrosis and Post Polycythemia Vera/Essential Thrombocythemia Myelofibrosis
Conditions: Myelofibrosis;   Polycythemia Vera;   Thrombocytosis
Intervention:
3 Recruiting Primary Thrombocythaemia 1 Trial
Conditions: Thrombocythemia;   Myeloproliferative Disorder
Intervention: Drug: Hydroxyurea + aspirin
4 Recruiting Polycythemia Vera, Myelofibrosis and Essential Thrombocythemia: Identification of PV, MF & ET Genes
Conditions: Polycythemia Vera;   Essential Thrombocythemia;   Myelofibrosis
Intervention:
5 Recruiting Study to Determine the Safety and Efficacy of INCB018424 in Patients With Polycythemia Vera or Essential Thrombocythemia
Conditions: Polycythemia Vera;   Essential Thrombocythemia
Interventions: Drug: INCB018424;   Drug: INCB018424;   Drug: INCB018424
6 Recruiting A Study of Anagrelide and Hydroxyurea in High-Risk Essential Thrombocythemia Patients
Condition: Thrombocythemia, Hemorrhagic
Interventions: Drug: Anagrelide;   Drug: Hydroxyurea
7 Recruiting Safety and Pregnancy Outcomes in Thrombocythemia Patients Exposed to Xagrid Compared to Other Treatments
Condition: Thrombocythemia, Essential
Intervention:
8 Recruiting Gene Changes and Biomarkers in Chronic Myeloproliferative Disorders
Conditions: Polycythemia Vera;   Essential Thrombocytosis;   Idiopathic Myelofibrosis;   Neutrophils;   Chronic Myeloproliferative Disorders
Intervention:
9 Completed A Phase II Study of the Pharmacokinetics of Anagrelide in Elderly and Young ET Patients
Condition: Essential Thrombocythaemia
Intervention: Drug: anagrelide hydrochloride
10 Recruiting CEP-701 (Lestaurtinib) in Myelofibrosis
Conditions: Myelofibrosis;   Essential Thrombocythemia;   Polycythemia Vera
Intervention: Drug: CEP-701 (Lestaurtinib)
11 Recruiting Research Tissue Bank
Conditions: Myelofibrosis;   Idiopathic Myelofibrosis;   Essential Thrombocythemia;   Polycythemia Vera
Intervention:
12 Recruiting A Phase 1/2 Study of Oral SB1518 in Subjects With Chronic Idiopathic Myelofibrosis
Conditions: Myelofibrosis;   Myeloproliferative Disorders;   Polycythemia Vera;   Essential Thrombocythemia
Intervention: Drug: SB1518
13 Recruiting Correlative Biomarker Study in Patients With Myeloproliferative Disorders
Conditions: Myeloproliferative Disease;   Myelofibrosis;   Idiopathic Myelofibrosis;   Essential Thrombocythemia;   Polycythemia Vera
Intervention:
14 Recruiting Familial Myeloproliferative Disorders
Conditions: Polycythemia Vera;   Essential Thrombocythemia;   Idiopathic Myelofibrosis
Intervention:
15 Suspended CC-4047 in Treating Patients With Polycythemia Vera or Essential Thrombocythemia and Myelofibrosis That Did Not Respond to Lenalidomide or Thalidomide
Conditions: Cancer-Related Problem/Condition;   Chronic Myeloproliferative Disorders
Interventions: Drug: CC-4047;   Procedure: questionnaire administration
16 Recruiting A Safety Study of XL019 in Adults With Myelofibrosis
Conditions: Myeloproliferative Disorders;   Myelofibrosis;   Polycythemia Vera;   Thrombocythemia, Essential
Intervention: Drug: XL019
17 Recruiting A Dose-Escalation Study of the Safety and Tolerability of Orally Administered TG101348 in Patients With Myelofibrosis
Condition: Myelofibrosis
Intervention: Drug: TG101348
18 Completed Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
Conditions: Breast Cancer;   Cancer-Related Problem/Condition;   Chronic Myeloproliferative Disorders;   Leukemia;   Lung Cancer;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Precancerous/Nonmalignant Condition;   Small Intestine Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: epoetin alfa;   Procedure: quality-of-life assessment
19 Completed Pyroxamide in Treating Patients With Advanced Cancer
Conditions: Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Precancerous/Nonmalignant Condition;   Small Intestine Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Drug: pyroxamide
20 Active, not recruiting Allogeneic Peripheral Stem Cell Transplantation Followed By Donor Lymphocyte Infusions in Treating Patients With Hematologic Cancer
Conditions: Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: fludarabine phosphate;   Drug: therapeutic allogeneic lymphocytes;   Procedure: allogeneic bone marrow transplantation;   Procedure: graft-versus-tumor induction therapy;   Procedure: peripheral blood stem cell transplantation;   Procedure: radiation therapy

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services